Jpmorgan Chase & CO Medtronic PLC Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Medtronic PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 30,044,606 shares of MDT stock, worth $2.43 Billion. This represents 0.22% of its overall portfolio holdings.
Number of Shares
30,044,606
Previous 28,565,053
5.18%
Holding current value
$2.43 Billion
Previous $2.25 Billion
20.31%
% of portfolio
0.22%
Previous 0.2%
Shares
14 transactions
Others Institutions Holding MDT
# of Institutions
2,288Shares Held
1.02BCall Options Held
8.05MPut Options Held
7.19M-
Vanguard Group Inc Valley Forge, PA123MShares$10 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY112MShares$9.07 Billion0.2% of portfolio
-
State Street Corp Boston, MA60.7MShares$4.92 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA32.6MShares$2.64 Billion0.63% of portfolio
-
Geode Capital Management, LLC Boston, MA26.5MShares$2.15 Billion0.2% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $108B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...